Advertisement

Molecular Biology Reports

, Volume 40, Issue 10, pp 5987–5992 | Cite as

Vascular endothelial growth factor (VEGF) gene polymorphisms and risk of head and neck cancer: a meta-analysis involving 2,444 individuals

  • Wei-Dong Leng
  • Mei-Ni He
  • Qi-Lin Chen
  • Heng Gong
  • Li Zhang
  • Xian-Tao Zeng
Article

Abstract

The association between vascular endothelial growth factor (VEGF) gene polymorphisms and risk of head and neck cancer (HNC) were investigated in many published studies; however, the currently available results are inconclusive. Therefore, we conducted this meta-analysis for deriving a more precise estimation of association between VEGF polymorphisms and the risk of HNC. Finally, we yield eight case–control studies involving six polymorphisms contain 2,444 individuals from PubMed, Embase, and CNKI up to January 30, 2013 (last updated on May 4, 2013). The results of meta-analysis showed that all the six polymorphisms of VEGF were not associated with risk of HNC [OR 1.25, 95 % CI (0.60–1.58) for TT vs. CC for 936 C/T; OR 1.41, 95 % CI (0.79–2.52) for GG vs. AA for −1,154 A/G; OR 0.97, 95 % CI (0.38–2.50) for CC vs. GG for 405 G/C; OR 1.44, 95 % CI (0.80–2.61) for AA vs. CC for 2,578 C/A; OR 1.27, 95 % CI (0.77–3.72) for TT vs. CC for −460 C/T; and OR 0.87, 95 % CI (0.37–2.06) for GG vs. CC for −634 G/C]. When performed subgroup analysis according to ethnicity for VEGF 936 C/T, the results suggested that it was not associated with the risk of HNC for either Asians [OR 0.84, 95 % CI (0.27–2.56) for TT vs. CC] or Caucasians [OR 2.10, 95 % CI (0.82–5.37) for TT vs. CC]. However, due to the limitations of this meta-analysis, more well designed, larger sample size, and adjusted risk factors studies are suggested to further assess the findings.

Keywords

Vascular endothelial growth factor Polymorphism Head and neck cancer Oral squamous cell carcinoma Laryngeal squamous cell carcinoma Meta-analysis 

Notes

Acknowledgments

This research was supported (in part) by the Nature Science Foundation of Hubei Province (2012FFB03902), the Natural Science Foundation of Hubei Ministry of Education (D20122405), the Foundation of Education and Science Planning Project of Hubei Province (2012A050), and the Intramural Research Program of the Hubei University of Medcine (2011CZX01), without commercial or not-for-profit sectors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.

Conflict of interest

None.

References

  1. 1.
    Curado MP, Hashibe M (2009) Recent changes in the epidemiology of head and neck cancer. Curr Opin Oncol 21:194–200PubMedCrossRefGoogle Scholar
  2. 2.
    Wozniak A, Szyfter K, Szyfter W, Florek E (2012) Head and neck cancer—history. Przegl Lek 69:1079–1083PubMedGoogle Scholar
  3. 3.
    Bouvard V, Baan R, Straif K et al (2009) A review of human carcinogens—part B: biological agents. Lancet Oncol 10:321–322PubMedCrossRefGoogle Scholar
  4. 4.
    Secretan B, Straif K, Baan R et al (2009) A review of human carcinogens—part E: tobacco, areca nut, alcohol, coal smoke, and salted fish. Lancet Oncol 10:1033–1034PubMedCrossRefGoogle Scholar
  5. 5.
    Hashibe M, Brennan P, Chuang SC et al (2009) Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiol Biomarkers Prev 18:541–550PubMedCrossRefGoogle Scholar
  6. 6.
    de Andrade M, Amos CI, Foulkes WD (1998) Segregation analysis of squamous cell carcinoma of the head and neck: evidence for a major gene determining risk. Ann Hum Genet 62:505–510PubMedCrossRefGoogle Scholar
  7. 7.
    Han L, Jiang B, Wu H et al (2012) High expression of CXCR2 is associated with tumorigenesis, progression, and prognosis of laryngeal squamous cell carcinoma. Med Oncol 29:2466–2472PubMedCrossRefGoogle Scholar
  8. 8.
    Yuan H, Niu YM, Wang RX, Li HZ, Chen N (2011) Association between XPD Lys751Gln polymorphism and risk of head and neck cancer: a meta-analysis. Genet Mol Res 10:3356–3364PubMedCrossRefGoogle Scholar
  9. 9.
    Chang JS, Straif K, Guha N (2012) The role of alcohol dehydrogenase genes in head and neck cancers: a systematic review and meta-analysis of ADH1B and ADH1C. Mutagenesis 27:275–286PubMedCrossRefGoogle Scholar
  10. 10.
    Cao C, Fang JJ, Ying T et al (2010) Vascular endothelial growth factor +936 C/T and +405 G/C polymorphisms and cancer risk: a meta-analysis. Arch Med Res 41:548–557PubMedCrossRefGoogle Scholar
  11. 11.
    Hong TT, Cai DY, Wu XH, Hua D (2011) Three vascular endothelial growth factor polymorphisms (−460 C>T, −2578 C>A, 1612 G>A) with cancer risk: a meta-analysis based on 30 case-control studies. Cancer Invest 29:472–477PubMedGoogle Scholar
  12. 12.
    Hong TT, Zhang RX, Wu XH, Hua D (2012) Polymorphism of vascular endothelial growth factor −1154 G>A (rs1570360) with cancer risk: a meta-analysis of 16 case-control studies. Mol Biol Rep 39:5283–5289PubMedCrossRefGoogle Scholar
  13. 13.
    Hu K, Zhang Y, Wang R, Li G, Zhang D (2012) Current evidence on VEGF +405 G/C polymorphism and malignancy susceptibility: a meta-analysis involving 30 studies. Twin Res Hum Genet 15:496–502PubMedCrossRefGoogle Scholar
  14. 14.
    Cao C, Ying T, Fang JJ et al (2011) Polymorphism of vascular endothelial growth factor −2578 C/A with cancer risk: evidence from 11263 subjects. Med Oncol 28:1169–1175PubMedCrossRefGoogle Scholar
  15. 15.
    Xu B, Li JM, Tong N et al (2010) VEGFA +936 C>T polymorphism and cancer risk: a meta-analysis. Cancer Genet Cytogenet 198:7–14PubMedCrossRefGoogle Scholar
  16. 16.
    Xu B, Feng NH, Tong N et al (2010) VEGF −460 C>T polymorphism and cancer risk: a meta-analysis. Med Oncol 27:1031–1036PubMedCrossRefGoogle Scholar
  17. 17.
    Liu L, Zeng F, Wang K, Huang J, Xin L, Zhu PQ (2011) Meta-analysis of the association between VEGF −634 G>C and risk of malignancy based on 23 case-control studies. J Cancer Res Clin Oncol 137:1027–1036PubMedCrossRefGoogle Scholar
  18. 18.
    Wells GA SB, O’Connell D, Peterson J, Welch V, Losos M, Tugwell P (2010) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. The Ottawa Health Research InstituteGoogle Scholar
  19. 19.
    Huedo-Medina TB, Sanchez-Meca J, Marin-Martinez F, Botella J (2006) Assessing heterogeneity in meta-analysis: Q statistic or I2 index? Psychol Methods 11:193–206PubMedCrossRefGoogle Scholar
  20. 20.
    Ku KT, Wan L, Peng HC, Tsai MH, Tsai CH, Tsai FJ (2005) Vascular endothelial growth factor gene −460 C/T polymorphism is a biomarker for oral cancer. Oral Oncol 41:497–502PubMedCrossRefGoogle Scholar
  21. 21.
    Cheng CY, Chang CS, Liu CJ, Kao SY (2008) Vascular endothelial growth factor 936 C/T polymorphism is associated with vascular invasion in oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 106:79–84PubMedCrossRefGoogle Scholar
  22. 22.
    Unal ZN, Unal M, Bagdatoglu OT, Polat G, Atik U (2008) Genetic polymorphism of VEGF −1154 (A/G) in laryngeal squamous cell carcinoma. Arch Med Res 39:209–211PubMedCrossRefGoogle Scholar
  23. 23.
    Vairaktaris E, Serefoglou Z, Avgoustidis D et al (2009) Gene polymorphisms related to angiogenesis, inflammation and thrombosis that influence risk for oral cancer. Oral Oncol 45:247–253PubMedCrossRefGoogle Scholar
  24. 24.
    Kammerer PW, Toyoshima T, Eletr S et al (2010) Single nucleotide polymorphisms of the vascular endothelial growth factor gene associated with incidence of oral squamous cell carcinoma. J Oral Pathol Med 39:786–792PubMedCrossRefGoogle Scholar
  25. 25.
    Ruiz MT, Biselli PM, Maniglia JV, Pavarino-Bertelli EC, Goloni-Bertollo EM (2010) Genetic variability of vascular endothelial growth factor and prognosis of head and neck cancer in a Brazilian population. Braz J Med Biol Res 43:127–133PubMedCrossRefGoogle Scholar
  26. 26.
    Lin YC, Yeh CJ, Wang LH, Lee CW, Chen CH (2012) The effect of CCND1 +870 A>G and VEGF +936 C>T polymorphisms on oral cancer development and disease-free survival in a Taiwan population. Oral Oncol 48:535–540PubMedCrossRefGoogle Scholar
  27. 27.
    Supic G, Jovic N, Zeljic K, Kozomara R, Magic Z (2012) Association of VEGF-A genetic polymorphisms with cancer risk and survival in advanced-stage oral squamous cell carcinoma patients. Oral Oncol 48:1171–1177PubMedCrossRefGoogle Scholar
  28. 28.
    Yapijakis C, Vairaktaris E, Vassiliou S et al (2007) The low VEGF production allele of the +936 C/T polymorphism is strongly associated with increased risk for oral cancer. J Cancer Res Clin Oncol 133:787–791PubMedCrossRefGoogle Scholar
  29. 29.
    Mandal RK, Yadav SS, Panda AK and Khattri S (2013) Vascular endothelial growth factor 936 C>T polymorphism increased oral cancer risk: evidence from a meta-analysis. Genet Test Mol Biomarkers 17:543–547Google Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2013

Authors and Affiliations

  • Wei-Dong Leng
    • 1
  • Mei-Ni He
    • 2
  • Qi-Lin Chen
    • 1
  • Heng Gong
    • 3
  • Li Zhang
    • 1
  • Xian-Tao Zeng
    • 1
  1. 1.Oral and Maxillofacial Surgery Laboratory, Department of Stomatology, School of Stomatology, Taihe HospitalHubei University of MedicineShiyanPeople’s Republic of China
  2. 2.Department of Operating Theatre, Taihe HospitalHubei University of MedicineShiyanPeople’s Republic of China
  3. 3.Department of Otolaryngology, Taihe HospitalHubei University of MedicineShiyanPeople’s Republic of China

Personalised recommendations